DNA proliferative index as a marker in Iraqi aneuploid mammary carcinoma

Eastern Mediterranean Health Journal

Volumn 6, Issue 5-6, 2000, Pages 1062-1072

  Al Alwan, N A S ^a  

^a UNIVERSITY OF BAGHDAD   (Iraq)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; DNA; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TUMOR MARKER;

ANEUPLOIDY; ARTICLE; BREAST TUMOR; CANCER STAGING; CHEMISTRY; CLASSIFICATION; FEMALE; GENETICS; HUMAN; IRAQ; MENOPAUSE; MIDDLE AGED; MITOSIS INDEX; NEEDLE BIOPSY; PAGET NIPPLE DISEASE; PATHOLOGY; PATIENT SELECTION; PLOIDY; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; VALIDATION STUDY;

ANEUPLOIDY; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DNA, NEOPLASM; FEMALE; HUMANS; IRAQ; MENOPAUSE; MIDDLE AGED; MITOTIC INDEX; NEOPLASM STAGING; PATIENT SELECTION; PLOIDIES; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034261462     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Remvikos Y et al. Proliferative activity of breast cancers increases in the course of genetic evolution as defined by cytogenetic analysis. Breast cancer research and treatment, 1992, 23:43-9.
2. Williams RA et al. Further testing of the value of a measurement protocol for DNA ploidy studies using image cytometry. Analytical and quantitative cytology and histology, 1996, 18:343-9.
3. Auer GU, Caspersson TO, Wallgren AS. DNA content and survival in mammary carcinoma. Analytical and quantitative cytology, 1980, 2:161-5.
4. Baldetorp B et al. Proliferative index obtained by DNA image cytometry. Does it add prognostic information in Auer IV breast cancer? Analytical and quantitative cytology and histology, 1998, 20(2): 144-52.
5. Zubrikhina GN et al. Vzaimootnosheniia mezhdu retseptorami steroidnykh gormonov, ploidnost'iu opukholi i pokazateliami kletochnoi proliferatsii pri razlichnykh histologicheskikh variantakh raka molochnoi zhelezy. [Relation of steroid receptors, tumour ploidy and cell proliferation in various histologic types of breast cancer.] Arkhiv patologii, 1989, 51(3):10-6.
6. Witzig TE et al. DNA ploidy and percent S-phase as prognostic factors in node positive breast cancer. Journal of clinical oncology, 1993, 11(2):351-60.
7. Leonardi E et al. Cytometric DNA analysis and prognostic biomarkers in breast carcinoma. Analytical cellular pathology, 1997, 15(1):31-45.
8. Azua J et al. Prognostic value from DNA quantification by static cytometry in breast carcinoma. Analytical and quantitative cytology and histology, 1997, 19:80-6.
9. Frei JV, Rizkalla K, Martinez VJ. Proliferative cell indices measured by DNA flow cytometry in node negative adenocarcinoma of breast. Modern pathology, 1994, 7(9):925-9.
10. Hiddemann W et al. Convention on nomenclature for DNA cytometry. Cytometry, 1984, 5:445-6.
11. Le Doussal V et al. Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas. Cancer, 1989, 64(9):1914-21.
12. Koss LG. Diagnostic cytology and its histopathologic bases, Vol. 2, 4th ed. Philadelphia, JB Lippincott, 1992:1293-314.
13. Tani E et al. Estrogen receptor contents in primary breast cancer and their metastases in fine-needle aspiration of metastatic lesions of gynecologic tumors. Gynecologic oncology, 1989, 32:365-7.
14. Marrazzo A et al. Immunocytochemical determination of estrogen and progesterone receptors in 219 FNA of breast cancer. A prospective study. Anticancer research, 1995, 15:521-6.
15. Beaglehole R, Bonita R, Kjellström T. Basic epidemiology. Geneva, World Health Organization, 1993:67-8.
16. Devita VT, Hellman S, Rosenberg SA. Cancer principles and practice of oncology, 2nd ed. Philadelphia, JB Lippincott, 1985.
17. Dressler LG et al. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer, 1988, 61(3):120-7.
18. Lewis WE. Prognostic significance of flow cytometric DNA analysis in node negative breast cancer patients. Cancer, 1990, 65:2315-20.
19. Al-Alwan NAS. Clinicocytopathologic evaluation of nuclear DNA ploidy and hormone receptor contents of breast tumours [PhD thesis]. Baghdad, Iraq, Baghdad University Medical College, 1998:95-116.
20. Auer GU et al. Progression of mammary adenocarcinoma as reflected by nuclear DNA content. Cytometry, 1984, 5:420-5.
21. Haghlom M et al. Correlation of flow cytometry to clinical features, hormone receptors and histopathological grade in stage I and II invasive breast carcinoma. American journal of clinical oncology, 1996, 19(1):54-8.
22. Usarevic D et al. Prognostic significance of cell cycle parameters in infiltrative ductal breast carcinoma. Journal of clinical laboratory analysis, 1998, 12(3):431-6.
23. Kute TE et al. Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer. Breast cancer research and treatment, 1985, 6:113-21.
24. Jakobsen A et al. Ploidy level of human breast cancer. Relation to histopathologic features and hormone receptor content. Acta radiologica. Oncology, 1984, 23(2-3):103-7.
25. Bychkeva NV, Pozharisskii KM. Aneuploidiia i proliferativnaia aktivnost' raka molochnoi zhelezy (protochno-tsitometricheskoe issledovanie). [Aneuploidy and proliferative activity in breast cancer.] Voprosy onkologii, 1997, 43(2): 171-5.
26. McCarty KS et al. A comparison of sex steroid receptor analysis and carcinoembryonic antigens with clinical response to hormone treatment. Cancer, 1980, 46:2846-50.
27. Sigurdsson H et al. Indicators of prognosis in node negative breast cancer. New England journal of medicine, 1990, 332: 1045-53.
28. Jensen V, Ladekarl M. Immunohistochemical quantitation of estrogen receptors and proliferative activity. Journal of clinical pathology, 1995, 48:429-2.